Featuring the lost science of the 1990s, a country-wide boycott of Elsevier subscriptions, plans to help society publishers embrace Plan S and the validity of preprints
Featuring the University of California’s split from Elsevier, opinions on Plan S from the Global South and the academic community and the rise in pharma research published open access
Featuring changes to clinical trial reporting and data sharing regulations, and criticism of Plan S from the perspective of highly selective subscription journals
Featuring a summary of the findings from the COMPare study, the success of transparent peer review pilot schemes and alternative methods for measuring academic career progression
Featuring proposals from Plan U, a call for stronger open access policies in the UK, the launch of UCL’s ‘megajournal’ and Elsevier’s controversial role in monitoring Europe’s open science movement.
Featuring highlights from the European Meeting of ISMPP, discrepancies in disclosure reporting and the time implications of introducing a data availability statement.
Featuring updates from the Open Pharma round table, the expansion of transparent peer review workflows and potential problems for scientific societies with Plan S compliance.
Featuring the financial lure towards predatory publishing, an editorial mass migration and the rise of open data sets.
Featuring the role of the research community in driving open access, global perceptions of Plan S, and the need for clearer guidelines on APC caps.
Featuring updates to ICMJE recommendations, concerns surrounding APCs and quality control in open access journals, and the route to efficient data citation.